Journal article
Optimization of single-fraction high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer: A preliminary report
Abstract
Fifty-one untreated patients with advanced squamous cell carcinoma of the thoracic esophagus were entered into a randomized prospective study. The patients were randomized into four study groups for intraluminal brachytherapy. Group A patients (n=12) received treatment with 10 Gy; group B (n=14), 12 Gy; group C (n=14), 15 Gy; and group D (n=11), 18 Gy of single- fraction high dose rate intraluminal brachytherapy. The patients were followed up …
Authors
Kulhavy M; Sur RK; Levin VC; Donde B; Luhana F
Journal
Endocurietherapy Hyperthermia Oncology, Vol. 11, No. 4, pp. 235–239
Publication Date
November 29, 1995
ISSN
8756-1689